Cambridge Investment Research Advisors’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,167
Closed -$16K 3298
2023
Q2
$16K Buy
15,167
+250
+2% +$233 ﹤0.01% 3135
2023
Q1
$20K Buy
14,917
+1,896
+15% +$2.71K ﹤0.01% 3103
2022
Q4
$20K Hold
13,021
﹤0.01% 3045
2022
Q3
$38K Sell
13,021
-9,999
-43% -$27.3K ﹤0.01% 2960
2022
Q2
$43K Buy
23,020
+700
+3% +$2.06K ﹤0.01% 2953
2022
Q1
$97K Buy
22,320
+1,000
+5% +$4.49K ﹤0.01% 3017
2021
Q4
$115K Buy
21,320
+6,144
+40% +$57.4K ﹤0.01% 3017
2021
Q3
$208K Buy
+15,176
New +$217K ﹤0.01% 2785

Other funds holding AMRS

Cambridge Investment Research Advisors's AMRS Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 15,167 shares — an estimated $16K sold.

Cambridge Investment Research Advisors first reported a position in AMRS in Q3 2021 and held it in 8 quarters. The position peaked at $208K in Q3 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,167 Amyris Inc. shares in Q3 2023, an estimated $16K.
  • Cambridge Investment Research Advisors first reported a position in Amyris Inc. in Q3 2021 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Amyris Inc. position peaked at $208K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.